• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病大脑中的电子传递链缺陷。

Electron transport chain defects in Alzheimer's disease brain.

作者信息

Parker W D, Parks J, Filley C M, Kleinschmidt-DeMasters B K

机构信息

Department of Neurology, University of Colorado School of Medicine, Denver.

出版信息

Neurology. 1994 Jun;44(6):1090-6. doi: 10.1212/wnl.44.6.1090.

DOI:10.1212/wnl.44.6.1090
PMID:8208407
Abstract

Previous work suggested a deficiency in the terminal complex of the mitochondrial electron transport chain, cytochrome c oxidase (COX), in platelet mitochondria of Alzheimer's disease (AD) patients. The present study extends this observation to AD brain mitochondria through assay of electron transport chain activities in mitochondria isolated from autopsied brain samples from AD patients (n = 9) and from controls with and without known neurologic disease (n = 8). AD brain mitochondria demonstrated a generalized depression of activity of all electron transport chain complexes. This depression was most marked in COX activity (p < 0.001). Concentrations of cytochromes b, c1, and aa3 were similar in AD and controls. The electron transport chain is defective in AD brain, and the defect centers about COX.

摘要

先前的研究表明,阿尔茨海默病(AD)患者血小板线粒体中的线粒体电子传递链终末复合物——细胞色素c氧化酶(COX)存在缺陷。本研究通过检测从AD患者(n = 9)以及有或无已知神经疾病的对照者(n = 8)的尸检脑样本中分离出的线粒体中的电子传递链活性,将这一观察结果扩展至AD脑线粒体。AD脑线粒体显示出所有电子传递链复合物活性普遍降低。这种降低在COX活性中最为明显(p < 0.001)。AD组和对照组中细胞色素b、c1和aa3的浓度相似。AD脑的电子传递链存在缺陷,且该缺陷集中在COX。

相似文献

1
Electron transport chain defects in Alzheimer's disease brain.阿尔茨海默病大脑中的电子传递链缺陷。
Neurology. 1994 Jun;44(6):1090-6. doi: 10.1212/wnl.44.6.1090.
2
Cytochrome oxidase deficiency in Alzheimer's disease.阿尔茨海默病中的细胞色素氧化酶缺乏症。
Neurology. 1990 Aug;40(8):1302-3. doi: 10.1212/wnl.40.8.1302.
3
Cytochrome c oxidase and mitochondrial F1F0-ATPase (ATP synthase) activities in platelets and brain from patients with Alzheimer's disease.阿尔茨海默病患者血小板和大脑中的细胞色素c氧化酶及线粒体F1F0 - ATP酶(ATP合酶)活性
Neurobiol Aging. 2002 May-Jun;23(3):371-6. doi: 10.1016/s0197-4580(01)00314-1.
4
Cytochrome c oxidase in Alzheimer's disease brain: purification and characterization.阿尔茨海默病大脑中的细胞色素c氧化酶:纯化与特性分析。
Neurology. 1995 Mar;45(3 Pt 1):482-6. doi: 10.1212/wnl.45.3.482.
5
Facilitation of brain mitochondrial activity by 5-aminolevulinic acid in a mouse model of Alzheimer's disease.5-氨基乙酰丙酸促进阿尔茨海默病小鼠模型的脑线粒体活性。
Nutr Neurosci. 2017 Nov;20(9):538-546. doi: 10.1080/1028415X.2016.1199114. Epub 2016 Jun 22.
6
A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients.阿尔茨海默病患者大脑中存在细胞色素c氧化酶的选择性缺陷。
Neurobiol Aging. 2000 May-Jun;21(3):455-62. doi: 10.1016/s0197-4580(00)00112-3.
7
Impairment in mitochondrial cytochrome oxidase gene expression in Alzheimer disease.阿尔茨海默病中线粒体细胞色素氧化酶基因表达受损。
Brain Res Mol Brain Res. 1994 Jul;24(1-4):336-40. doi: 10.1016/0169-328x(94)90147-3.
8
The expression of several mitochondrial and nuclear genes encoding the subunits of electron transport chain enzyme complexes, cytochrome c oxidase, and NADH dehydrogenase, in different brain regions in Alzheimer's disease.阿尔茨海默病不同脑区中,几种编码电子传递链酶复合物亚基、细胞色素c氧化酶和NADH脱氢酶的线粒体和核基因的表达情况。
Neurochem Res. 1999 Jun;24(6):767-74. doi: 10.1023/a:1020783614031.
9
The role of cytochrome c oxidase deficient hippocampal neurones in Alzheimer's disease.细胞色素c氧化酶缺陷型海马神经元在阿尔茨海默病中的作用。
Neuropathol Appl Neurobiol. 2002 Oct;28(5):390-6. doi: 10.1046/j.1365-2990.2002.00414.x.
10
Cytochrome c oxidase in Alzheimer's disease.阿尔茨海默病中的细胞色素c氧化酶
Neurology. 1995 Jul;45(7):1423. doi: 10.1212/wnl.45.7.1423.

引用本文的文献

1
ROS-dependent localization of glycolytic enzymes to mitochondria.糖酵解酶基于活性氧的线粒体定位
Redox Biol. 2025 Aug 12;86:103812. doi: 10.1016/j.redox.2025.103812.
2
Alzheimer's Disease Pathogenic Mechanisms: Linking Redox Homeostasis and Mitochondria-Associated Metabolic Pathways Through Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2).阿尔茨海默病的致病机制:通过核因子红细胞2相关因子2(Nrf2)连接氧化还原稳态与线粒体相关代谢途径
Antioxidants (Basel). 2025 Jul 1;14(7):812. doi: 10.3390/antiox14070812.
3
scGraph2Vec: a deep generative model for gene embedding augmented by graph neural network and single-cell omics data.
scGraph2Vec:一种由图神经网络和单细胞组学数据增强的用于基因嵌入的深度生成模型。
Gigascience. 2024 Jan 2;13. doi: 10.1093/gigascience/giae108.
4
MAD-microbial (origin of) Alzheimer's disease hypothesis: from infection and the antimicrobial response to disruption of key copper-based systems.MAD-微生物(起源的)阿尔茨海默病假说:从感染和抗菌反应到关键铜基系统的破坏
Front Neurosci. 2024 Oct 2;18:1467333. doi: 10.3389/fnins.2024.1467333. eCollection 2024.
5
Increasing hexokinase 1 expression improves mitochondrial and glycolytic functional deficits seen in sporadic Alzheimer's disease astrocytes.增加己糖激酶1的表达可改善散发性阿尔茨海默病星形胶质细胞中出现的线粒体和糖酵解功能缺陷。
Mol Psychiatry. 2025 Apr;30(4):1369-1382. doi: 10.1038/s41380-024-02746-8. Epub 2024 Sep 13.
6
Exploring the Mechanisms and Therapeutic Approaches of Mitochondrial Dysfunction in Alzheimer's Disease: An Educational Literature Review.探索阿尔茨海默病中线粒体功能障碍的机制和治疗方法:一篇教育性文献综述。
Mol Neurobiol. 2025 Jun;62(6):6785-6810. doi: 10.1007/s12035-024-04468-y. Epub 2024 Sep 10.
7
Mitochondrial Targeting against Alzheimer's Disease: Lessons from Hibernation.线粒体靶向治疗阿尔茨海默病:来自冬眠的启示。
Cells. 2023 Dec 20;13(1):12. doi: 10.3390/cells13010012.
8
Effects of Redox Homeostasis and Mitochondrial Damage on Alzheimer's Disease.氧化还原稳态和线粒体损伤对阿尔茨海默病的影响。
Antioxidants (Basel). 2023 Sep 30;12(10):1816. doi: 10.3390/antiox12101816.
9
Creatine as a Therapeutic Target in Alzheimer's Disease.肌酸作为阿尔茨海默病的治疗靶点
Curr Dev Nutr. 2023 Sep 29;7(11):102011. doi: 10.1016/j.cdnut.2023.102011. eCollection 2023 Nov.
10
Amyloid-β Pathology-Specific Cytokine Secretion Suppresses Neuronal Mitochondrial Metabolism.淀粉样β蛋白病理学特异性细胞因子分泌抑制神经元线粒体代谢。
Cell Mol Bioeng. 2023 Sep 11;16(4):405-421. doi: 10.1007/s12195-023-00782-y. eCollection 2023 Aug.